HomeIndiaGraph AI Secures $3M Seed Funding Led by Bessemer Venture Partners

Graph AI Secures $3M Seed Funding Led by Bessemer Venture Partners

Graph AI Secures $3M Seed Funding Led by Bessemer Venture Partners

Graph AI, a California-based life sciences company focused on patient safety and drug monitoring, has raised $3 million in seed funding, led by Bessemer Venture Partners.

The startup will use the money to develop new products, expand its engineering team, and grow its presence in global markets.

“We realised that the life sciences industry had a significant amount of tech debt and a lot of archaic systems, a lot of federated and fragmented technologies. We immediately found an opportunity to take that fragmentation and consolidate it into a SaaS platform-based approach,” cofounder and CEO Raghav Parvataraju said.

“We hire domain experts along with tech talent, and our AI expertise is in-house. The team includes customer success, customer care and data engineering roles,” he said.

Nithin Kaimal, Partner and COO at Bessemer Venture Partners India, said in a statement, “We are excited to partner with Graph AI as they transform labor-intensive pharmacovigilance workflows through AI-native solutions that prioritize accuracy and scalability. This shift from labor arbitrage to intelligence arbitrage represents a new era where faster, smarter, and more adaptive solutions are becoming the norm.”

Graph AI was founded in 2024 by Parvataraju, Vijay Ponukumati (CTO), Mohan Konyala (CPO), and Ashutosh Bordekar (CFO).

The California-based company aims to transform pharmacovigilance, which is the continuous monitoring and reporting of adverse drug events throughout a drug’s lifecycle.

Pharmaceutical companies have traditionally relied on large service providers that use manual and fragmented processes, which are often slow and prone to errors.

Graph AI solves these problems with an AI-powered automation platform that simplifies workflows, reduces manual work, and ensures faster and more accurate compliance with regulations.

The startup works with four main types of customers: pharmaceutical companies, biotech firms, cosmetic brands, and clinical research organizations or BPOs, according to Parvataraju.

Its biggest market is the US, followed by Europe, which sets much of the global regulatory rules, and then the Asia-Pacific region, including India, Japan, and China.

Headquartered in California, Graph AI has 18 employees. The founding team is in Silicon Valley, engineering operations are mainly in Hyderabad, India, and there are additional team members in Bogotá, Colombia.

Read more- Israeli AI startup ARGU raises $2 million pre-seed funding

- Advertisement -
RELATED ARTICLES
- Advertisment -

Most Popular